The Novo Nordisk Foundation

 The Novo Nordisk Foundation ( is an independent Danish foundation with corporate interests. The Foundation provides support to scientific, humanitarian and social purposes. Its vision is to contribute significantly to research and development that improves the lives of people and the sustainability of society.

The Copenhagen Bioscience Cluster ( is a Novo Nordisk Foundation initiative to strengthen biomedicine and biotechnology research and innovation in Denmark and create an innovative framework for collaboration and synergy. Four major research centers, three infrastructures and a number of supporting initiatives form the backbone of the Copenhagen Bioscience Cluster. Located in Greater Copenhagen, the Cluster is surrounded by a rich life science environment including several universities and university hospitals, as well as a large number of life science companies. The Cluster provides great opportunities for interaction and collaboration.

Through a series of donations, the Novo Nordisk Foundation has supported the establishment and growth of DanStem as well as a variety of Copenhagen Bioscience Cluster initiatives that promote our science and facilitate networking and the professional development of our scientists.

  • In 2011, DanStem received a grant from the Novo Nordisk Foundation to establish an international research center for basic stem cell and developmental biology research.
  • In 2015, DanStem received an additional grant from the Novo Nordisk Foundation to strengthen and expand the Center’s activities with investments in technologies related to single cell analysis as well as new research areas, including pancreatic cancer, by recruiting new junior group leaders.
  • In 2017, DanStem received a new grant from the Novo Nordisk Foundation to support translational research in blood cancers and diabetes.

Read more about the Novo Nordisk Foundation.

press releases

Denmark forges a new direction in stem cell research 
New grant for cutting-edge clinical research to help shape future therapies